| P2093 | author name string | Fevzi Nuri Aydin | |
| | Taner Ozgurtas | |
| | Hakan Durukan | |
| | Mehmet Ozler | |
| | Umut Karaca | |
| | Fatih Yesildal | |
| | Muhammed Talha Ugurlu | |
| | Sercan Tekin | |
| P2860 | cites work | Vaso-obliteration in the canine model of oxygen-induced retinopathy | Q71007160 |
| | Oxygen-induced retinopathy in the mouse | Q71608431 |
| | The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats | Q72016846 |
| | Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat | Q72094685 |
| | Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat | Q72650581 |
| | What can We learn from STOP-ROP and earlier studies? | Q73401263 |
| | A double-edged sword: erythropoietin eyed in retinopathy of prematurity | Q81038093 |
| | Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin) | Q83180985 |
| | Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity | Q24609568 |
| | Hypoxia-induced retinal angiogenesis in zebrafish as a model to study retinopathy | Q33354053 |
| | Animal models of choroidal and retinal neovascularization | Q33582933 |
| | Current incidence of retinopathy of prematurity, 1989-1997. | Q33724033 |
| | Retinal and choroidal neovascularization | Q33980639 |
| | Are we there yet? Bevacizumab therapy for retinopathy of prematurity | Q34114985 |
| | Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors | Q34150725 |
| | Fibroblastic Overgrowth of Persistent Tunica Vasculosa Lentis in Infants Born Prematurely: II. Report of Cases-Clinical Aspects | Q34225851 |
| | Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control | Q37072107 |
| | The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge | Q38101684 |
| | Endothelial cell-dependent regulation of arteriogenesis | Q39375877 |
| | Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia | Q40935597 |
| | Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity | Q42155672 |
| | Changes in causes of low vision between 1988 and 2009 in a Dutch population of children | Q43439899 |
| | Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants | Q47429900 |
| | Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity | Q47629197 |
| | Logistic analysis of risk factors in acute retinopathy of prematurity. | Q52429153 |
| | The progression of retinopathy of prematurity and fluctuation in blood gas tension. | Q53390653 |
| | Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. | Q53793126 |
| | PlGF gene knockdown in human retinal pigment epithelial cells. | Q54400583 |
| | Retinopathy of prematurity | Q60439193 |
| | Fluorescein Angiography in Retrolental Fibroplasia | Q67021481 |
| | Oxygen-induced retinopathy in newborn rats: effects of prolonged normobaric and hyperbaric oxygen supplementation | Q68457393 |
| | Oxygen-induced proliferative retinopathy in the newborn rat | Q68817731 |
| | Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National Collaborative Study on Patent Ductus Arteriosus in Premature Infants | Q69869379 |
| | Variable oxygen exposure causes preretinal neovascularization in the newborn rat | Q70600600 |
| P433 | issue | 9 | |
| P921 | main subject | retinopathy of prematurity | Q1423087 |
| P304 | page(s) | 1265-1270 | |
| P577 | publication date | 2016-09-18 | |
| P1433 | published in | International Journal of Ophthalmology | Q26841911 |
| P1476 | title | A novel model of retinopathy of prematurity in normobaric hyperoxic conditions | |
| P478 | volume | 9 | |